產(chǎn)品中心Cell Resources
聯(lián)系我們CONTACT US
400-999-210024小時(shí)服務(wù)熱線
產(chǎn)品概述
| 名稱 | 5637 (人膀胱癌細(xì)胞) (STR鑒定正確) |
| 種屬 | 人 |
| 生長(zhǎng)特性 | 貼壁細(xì)胞 |
| 細(xì)胞形態(tài) | 上皮細(xì)胞樣 |
| 凍存條件 | 凍存液：55% 基礎(chǔ)培養(yǎng)基+40%FBS+5%DMSO 溫度：液氮 |
| 培養(yǎng)方案A（默認(rèn)） |
培養(yǎng)條件:
氣相：空氣，95%；CO2，5%, 溫度：37℃
|
| 推薦傳代比例 | 1:3-1:4 |
| 推薦換液頻率 | 2-3次/周 |
| 注意事項(xiàng) | 該細(xì)胞較難消化，注意延長(zhǎng)消化時(shí)間，消化到細(xì)胞收縮變圓，輕拍培養(yǎng)瓶側(cè)邊，細(xì)胞可以滑落方可終止消化。 |
| 背景描述 | 5637細(xì)胞能生成SCF、IL-1、IL-3、IL-6、G-CSF、GM-CSF等。 |
| 年齡（性別） | 男性；68歲 |
| 組織來(lái)源 | 膀胱；癌 |
| 細(xì)胞類型 | 腫瘤細(xì)胞 |
| 腫瘤類型 | 膀胱癌細(xì)胞 |
| 生物安全等級(jí) | BSL-1 |
| 倍增時(shí)間 | ~24-36 hours |
| 致瘤性 | Yes, within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 1×10^7 cells. |
| 保藏機(jī)構(gòu) | ATCC; HTB-9 DSMZ; ACC-35 |
STR鑒定
-
STR位點(diǎn)信息
Amelogenin X CSF1PO 11 D2S1338 25 D3S1358 15,17 D5S818 11,12 D7S820 10,11 D8S1179 10,16 D13S317 11 D16S539 9 D18S51 16,18 D19S433 13,15 D21S11 36 FGA 22 PentaD 11 PentaE 10,12 TH01 7,9 TPOX 8 vWA 18 D6S1043 16,20 D12S391 20 D2S441 14 -
STR鑒定圖
-
參考文獻(xiàn)
-
Enhanced exosome capture in urine using aptamer-modified temperature-responsive polymer for sensitive early detection of bladder cancer(2024/04/16)
作者：Min Liu, Kezhen Yi, Yaran Zhang
期刊：CHEMICAL ENGINEERING JOURNAL
影響因子 ：15.100
引用產(chǎn)品：CL-0002
-
Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D(2018/11/27)
作者：Zhe Qiang, Zongyuan Zhou, Ting Peng
期刊：Journal Of Experimental & Clinical Cancer Research
影響因子 ：11.300
引用產(chǎn)品：CL-0002
-
WD repeat protein 54-mediator of ErbB2-driven cell motility 1 axis promotes bladder cancer tumorigenesis and metastasis and impairs chemosensitivity(2023/01/07)
作者：Xiaosong Wei, Beibei Wang, Zixin Wu
期刊：CANCER LETTERS
DOI：10.1016/j.canlet.2023.216058
影響因子 ：9.700
引用產(chǎn)品：CL-0002 CL-0125 CL-0222 CL-0227 CL-0463 CL-0628 PM150410 PM150710 PM150910 PM151010
-
A novel CD8+ T cell-related gene signature for predicting the prognosis and immunotherapy efficacy in bladder cancer(2023/08/14)
作者：Fei Lin, Zhibin Ke, Yuting Xue
期刊：INFLAMMATION RESEARCH
DOI：10.1007/s00011-023-01772-6
影響因子 ：6.700
-
Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction(2022/11/02)
作者：Xiaoyue Lyu, Yujie Qiang, Bo Zhang
期刊：Frontiers in Oncology
影響因子 ：5.738
引用產(chǎn)品：CL-0002
-
Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.(2022/09/21)
作者：Longfei Yang, Yuwei Zhang, Yang Wang
期刊：Frontiers in Pharmacology
影響因子 ：5.600
引用產(chǎn)品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910
-
MiR-362-5p, Which Is Regulated by Long Non-Coding RNA MBNL1-AS1, Promotes the Cell Proliferation and Tumor Growth of Bladder Cancer by Targeting QKI(2020/03/03)
作者：Xiaosong Wei, Beibei Wang, Qi Wang
期刊：Frontiers in Pharmacology
影響因子 ：5.600
-
Cytotoxic and Antibacterial Meroterpenoids Isolated from the Marine-Derived Fungus Talaromyces sp. M27416(2024/04/20)
作者：Lingzhi Tang, Jinmei Xia, Zhongwei Chen
期刊：Marine Drugs
影響因子 ：5.400
引用產(chǎn)品：CL-0002
-
CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway(2021/11/24)
作者：Jianghua Yang, Li Fan, Xiaoxing Liao
期刊：Bioengineered
DOI：10.1080/21655979.2021.1974645
影響因子 ：4.900
-
Transcriptomic profiling and risk assessment in bladder cancer: Insights from copper death-related genes(2024/05/27)
作者：Xu Wang, Long Jin, Xiaoyu Zhang
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2024.111237
影響因子 ：4.800
引用產(chǎn)品：CL-0002
-
POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer(2023/11/07)
作者：Hualin Chen, Lin Ma, Wenjie Yang
期刊：FASEB JOURNAL
影響因子 ：4.800
引用產(chǎn)品：CL-0002
-
The oncogenic role of TFAP2A in bladder urothelial carcinoma via a novel long noncoding RNA TPRG1-AS1/DNMT3A/CRTAC1 axis(2022/11/21)
作者：Jiani He, Changming Dong, Hao Zhang, Yuanjun Jiang, Tao Liu, Xiaojun Man
期刊：CELLULAR SIGNALLING
DOI：10.1016/j.cellsig.2022.110527
影響因子 ：4.800
-
A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance(2023/04/08)
作者：Longfei Yang, Yuwei Zhang, Yifan Tang
期刊：Scientific Reports
DOI：10.1038/s41598-023-27975-9
影響因子 ：4.600
引用產(chǎn)品：CL-0002 CL-0010 CL-0052 CL-0075 CL-0109 CL-0185 CL-0222 CL-0227 CM-H019 PM150110 PM150210 PM150910
-
A novel anoikis-related gene signature identifies LYPD1 as a novel therapy target for bladder cancer(2024/02/08)
作者：Zhen Song, Shikai Gui, Shuaiyun Xiao
期刊：Scientific Reports
DOI：10.1038/s41598-024-53272-0
影響因子 ：4.600
引用產(chǎn)品：CL-0002
-
Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis(2024/02/02)
作者：Han Wang, Junjie Liu, Yanyan Lou
期刊：Scientific Reports
DOI：10.1038/s41598-024-53265-z
影響因子 ：4.600
引用產(chǎn)品：CL-0002
-
NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway( 2022/01/02)
作者：Bo Li, Qian Xiao, Liping Shan
期刊：Cell Cycle
DOI：10.1080/15384101.2021.2021050
影響因子 ：4.300
-
Meta-biosensor with High Q-factor Based on Wet Etching for Terahertz Detection(2024/02/27)
作者：Xueer Chen, Longfang Ye, Daquan Yu
期刊：IEEE SENSORS JOURNAL
影響因子 ：4.300
引用產(chǎn)品：CL-0002
-
CircRPPH1 accelerates the proliferation and migration of bladder cancer via enhancing the STAT3 signaling pathway(2023/03/31)
作者：Xiao Liu, Yonghua Tong, Qiu Huang
期刊：ONCOLOGY REPORTS
影響因子 ：4.200
-
Comprehensive analysis indicated that NDE1 is a potential biomarker for pan-cancer and promotes bladder cancer progression(2024/03/11)
作者：Peihan Wang, Jinzhuo Ning, Wu Chen
期刊：Cancer Medicine
影響因子 ：4.000
引用產(chǎn)品：CL-0002
-
LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR‐135a‐5p/PHLPP2/FOXO1 axis in bladder cancer(2019/11/25)
作者：Xiaosong Wei, Xiaoming Yang, Beibei Wang
期刊：Cancer Medicine
影響因子 ：4.000
引用產(chǎn)品：CL-0002
-
CENPW knockdown inhibits progression of bladder cancer through inducing cell cycle arrest and apoptosis(2024/01/01)
作者：Peng Zhang, Qian Yang, Xulong Chen
期刊：Journal of Cancer
影響因子 ：3.900
引用產(chǎn)品：CL-0002
-
circCEP128 Knockdown Suppresses Bladder Cancer Progression via Regulating microRNA-515-5p/SDC1 Axis(2022/12/21)
作者：Guanghui Cao, Chan Zhang, Xiangyong Tian
期刊：Cancer Management and Research
影響因子 ：3.602
引用產(chǎn)品：CL-0002
-
Rad54L promotes bladder cancer progression by regulating cell cycle and cell senescence(2022/09/07)
作者：Yinzhao Wang, Tailai Zhou, Hengxing Chen
期刊：MEDICAL ONCOLOGY
DOI：10.1007/s12032-022-01751-7
影響因子 ：3.400
-
HEATR3 involved in the cell proliferation, metastasis and cell cycle development of bladder cancer acts as a tumor suppressor(2023/07/31)
作者：Xia Dou, Xiaoya Ma, Wenting Meng
期刊：MOLECULAR GENETICS AND GENOMICS
DOI：10.1007/s00438-023-02046-w
影響因子 ：3.100
-
Fatty acid metabolism-related molecular subtypes and a novel model for predicting prognosis in bladder cancer patients(2024/01/05)
作者：Wenting Su, Jiayin Chen, Jiangbo Sun
期刊：JOURNAL OF BIOSCIENCES
DOI：10.1007/s12038-023-00383-x
影響因子 ：2.900
引用產(chǎn)品：CL-0002
-
Effect of isorhamnetin on carbonic anhydrase IX expression and tumorigenesis of bladder cancer by activating PPARγ/PTEN/AKT pathway(2023/03/02)
作者：Peng Zhang, Yisheng Sun, Lei Shi
期刊：TISSUE & CELL
DOI：10.1016/j.tice.2023.102048
影響因子 ：2.600
引用產(chǎn)品：CL-0002
-
Hsa_circ_0008035 Knockdown Inhibits Bladder Cancer Progression through miR-1184/RAP2B Axis(2023/03/23)
作者：Yang Fu, Kun Liu, Xi Jiang
期刊：UROLOGIA INTERNATIONALIS
影響因子 ：1.600
FAQs
Q：{{item.question}}
A：
產(chǎn)品資料
識(shí)別碼示意圖
![NCI-H1568 [H1568] (人非小細(xì)胞肺癌細(xì)胞) (STR鑒定正確)](/Public/upfile/pic/xbx/CL-0690-1.jpg)
娜胡文君.png "邱國(guó)娜/胡文君")
.png "梅文強(qiáng)")
